SI-B003

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for SI-B003, covering 2025-09-26 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

See pricing